Co-Authors
This is a "connection" page, showing publications co-authored by STACEY PEREIRA and AMY MCGUIRE.
Connection Strength
5.499
-
Airmen and health-care providers' attitudes toward the use of genomic sequencing in the US Air Force: findings from the MilSeq Project. Genet Med. 2020 12; 22(12):2003-2010.
Score: 0.743
-
Return of individual genomic research results: what do consent forms tell participants? Eur J Hum Genet. 2016 11; 24(11):1524-1529.
Score: 0.557
-
Open access data sharing in genomic research. Genes (Basel). 2014 Aug 29; 5(3):739-47.
Score: 0.491
-
"Holy Cow, Where do I Sign up?" Attitudes of Military Veterans Toward Epigenomic Biomarker Toxic Exposure Testing. Mil Med. 2024 Sep 23.
Score: 0.247
-
"Holy cow, where do I sign up?" Attitudes of Military Veterans toward Epigenomic Biomarker Toxic Exposure Testing. medRxiv. 2024 Apr 18.
Score: 0.240
-
Parents' decision-making regarding whether to receive adult-onset only genetic findings for their children: Findings from the BabySeq Project. Genet Med. 2023 03; 25(3):100002.
Score: 0.218
-
Key drivers of family-level utility of pediatric genomic sequencing: a qualitative analysis to support preference research. Eur J Hum Genet. 2023 04; 31(4):445-452.
Score: 0.217
-
Patient and Clinician Perceptions of Precision Cardiology Care: Findings From the HeartCare Study. Circ Genom Precis Med. 2022 12; 15(6):e003605.
Score: 0.216
-
Family secrets: Experiences and outcomes of participating in direct-to-consumer genetic relative-finder services. Am J Hum Genet. 2022 03 03; 109(3):486-497.
Score: 0.206
-
Psychosocial Effect of Newborn Genomic Sequencing on Families in the BabySeq Project: A Randomized Clinical Trial. JAMA Pediatr. 2021 11 01; 175(11):1132-1141.
Score: 0.202
-
Pediatric Oncologists' Experiences Returning and Incorporating Genomic Sequencing Results into Cancer Care. J Pers Med. 2021 Jun 18; 11(6).
Score: 0.197
-
Responsibility, culpability, and parental views on genomic testing for seriously ill children. Genet Med. 2019 12; 21(12):2791-2797.
Score: 0.171
-
Perceived Benefits, Risks, and Utility of Newborn Genomic Sequencing in the BabySeq Project. Pediatrics. 2019 01; 143(Suppl 1):S6-S13.
Score: 0.166
-
Do privacy and security regulations need a status update? Perspectives from an intergenerational survey. PLoS One. 2017; 12(9):e0184525.
Score: 0.152
-
Should you profit from your genome? Nat Biotechnol. 2017 01 10; 35(1):18-20.
Score: 0.145
-
The ethics of conducting molecular autopsies in cases of sudden death in the young. Genome Res. 2016 09; 26(9):1165-9.
Score: 0.140
-
Potential Psychosocial Risks of Sequencing Newborns. Pediatrics. 2016 Jan; 137 Suppl 1:S24-9.
Score: 0.135
-
Adult genetic risk screening. Annu Rev Med. 2014; 65:1-17.
Score: 0.116
-
The BabySeq Project: A clinical trial of genome sequencing in a diverse cohort of infants. Am J Hum Genet. 2024 Oct 03; 111(10):2094-2106.
Score: 0.062
-
Research Participants' Perspectives on Precision Diagnostics for Alzheimer's Disease. J Alzheimers Dis. 2024; 97(3):1261-1274.
Score: 0.059
-
Participant perceptions of changes in psychosocial domains following participation in an adaptive deep brain stimulation trial. Brain Stimul. 2023 Jul-Aug; 16(4):990-998.
Score: 0.056
-
Actionability of unanticipated monogenic disease risks in newborn genomic screening: Findings from the BabySeq Project. Am J Hum Genet. 2023 07 06; 110(7):1034-1045.
Score: 0.056
-
Parental Attitudes Toward Standard Newborn Screening and Newborn Genomic Sequencing: Findings From the BabySeq Study. Front Genet. 2022; 13:867371.
Score: 0.052
-
Researcher Views on Changes in Personality, Mood, and Behavior in Next-Generation Deep Brain Stimulation. AJOB Neurosci. 2023 Jul-Sep; 14(3):287-299.
Score: 0.052
-
Researchers' Ethical Concerns About Using Adaptive Deep Brain Stimulation for Enhancement. Front Hum Neurosci. 2022; 16:813922.
Score: 0.052
-
Patient, Caregiver, and Decliner Perspectives on Whether to Enroll in Adaptive Deep Brain Stimulation Research. Front Neurosci. 2021; 15:734182.
Score: 0.050
-
Genetic testing in ambulatory cardiology clinics reveals high rate of findings with clinical management implications. Genet Med. 2021 12; 23(12):2404-2414.
Score: 0.050
-
Effects of participation in a U.S. trial of newborn genomic sequencing on parents at risk for depression. J Genet Couns. 2022 02; 31(1):218-229.
Score: 0.050
-
Researcher Perspectives on Data Sharing in Deep Brain Stimulation. Front Hum Neurosci. 2020; 14:578687.
Score: 0.048
-
Researcher Perspectives on Ethical Considerations in Adaptive Deep Brain Stimulation Trials. Front Hum Neurosci. 2020; 14:578695.
Score: 0.047
-
Neuroethics at 15: Keep the Kant but Add More Bacon. AJOB Neurosci. 2019 Jul-Sep; 10(3):97-100.
Score: 0.043
-
Predispositional genome sequencing in healthy adults: design, participant characteristics, and early outcomes of the PeopleSeq Consortium. Genome Med. 2019 02 27; 11(1):10.
Score: 0.042
-
Returning a Genomic Result for an Adult-Onset Condition to the Parents of a Newborn: Insights From the BabySeq Project. Pediatrics. 2019 01; 143(Suppl 1):S37-S43.
Score: 0.041
-
Parental interest in genomic sequencing of newborns: enrollment experience from the BabySeq Project. Genet Med. 2019 03; 21(3):622-630.
Score: 0.041
-
The BabySeq project: implementing genomic sequencing in newborns. BMC Pediatr. 2018 07 09; 18(1):225.
Score: 0.040
-
Newborn Sequencing in Genomic Medicine and Public Health. Pediatrics. 2017 Feb; 139(2).
Score: 0.036
-
An open access pilot freely sharing cancer genomic data from participants in Texas. Sci Data. 2016 Feb 16; 3:160010.
Score: 0.034
-
Personalized genomic disease risk of volunteers. Proc Natl Acad Sci U S A. 2013 Oct 15; 110(42):16957-62.
Score: 0.029